EQL Pharma launch a combined Covid-19 and influenza A/B antigen self-test
EQL Pharma has today, as an exclusive supplier, launched a brand new combined Covid-19 and influenza (A+B) antigen self-test from Alltest. With a single sampling from the nasal cavity, the test detects Covid-19 and/or influenza (type A and B – the most common variants). The test is of great use in circumstances where it is important to determine which virus that caused the infection, to be able to foresee potential outcomes, risks, and decide on treatment options.The self-test has 96,99% sensitivity to Covid-19, 95,77% sensitivity to influenza type A and 94,12% sensitivity to the less